Department of Obstetrics & Gynaecology, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
Department of Obstetrics & Gynaecology, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
Taiwan J Obstet Gynecol. 2023 Jan;62(1):45-49. doi: 10.1016/j.tjog.2022.10.004.
The dilemma in treating cervical high-grade squamous intraepithelial lesion (HSIL) is how to achieve complete excision to minimize the risk of cervical cancer while sparing the anatomy of the cervix and its ability to function during pregnancy. The optimal management for positive margins after excisional treatment is still controversial. This study was conducted to determine the clinical and histologic predictors of residual/recurrent HSIL and assess the outcome of women with positive margin.
This retrospective cohort study included 386 women who had excisional treatment for HSIL during 1st January 2012 to 31st December 2015 in a university-affiliated hospital.
Overall, 212 (54.9%) women had negative margins and 155 (40.2%) had positive margins. The cumulative rate of residual/recurrent HSIL at 2 and 5 years was 15.7% and 16.8% respectively in positive margins and 1.8% and 5.0% respectively in negative margins (p < 0.001). Of women who had residual/recurrent HSIL, significantly more women had positive margins compared to negative margins (74.1% vs 25.9%, p = 0.001). Positive margin was significantly associated with higher rate of subsequent abnormal cervical smear (48.2% vs 28.9%, p < 0.001), requiring further colposcopy (32.1% vs 14.4%, p < 0.001) and further treatment for SIL (7.5% vs 4.8%, p < 0.001) compared to negative margin.
Most women (85%) with positive margin went without residual/recurrent HSIL, of which the option of close surveillance with cytology is reasonable. Repeat excision may be considered in selected women with positive margin, endocervical glandular involvement and those who are older or unable to comply with follow-up.
治疗宫颈高级别鳞状上皮内病变(HSIL)的困境在于如何实现完全切除,以最大程度地降低宫颈癌的风险,同时保留宫颈的解剖结构及其在怀孕期间的功能。对于切除治疗后阳性边缘的最佳处理仍存在争议。本研究旨在确定残留/复发 HSIL 的临床和组织学预测因素,并评估阳性边缘女性的结局。
这是一项回顾性队列研究,纳入了 2012 年 1 月 1 日至 2015 年 12 月 31 日期间在一所大学附属医院接受 HSIL 切除术的 386 名女性。
总体而言,212 名(54.9%)女性边缘阴性,155 名(40.2%)边缘阳性。阳性边缘的残留/复发 HSIL 累积率在 2 年和 5 年时分别为 15.7%和 16.8%,而阴性边缘的累积率分别为 1.8%和 5.0%(p<0.001)。在残留/复发 HSIL 的女性中,阳性边缘的女性明显多于阴性边缘(74.1% vs. 25.9%,p=0.001)。阳性边缘与更高的后续异常宫颈涂片率显著相关(48.2% vs. 28.9%,p<0.001),需要进一步行阴道镜检查(32.1% vs. 14.4%,p<0.001)和进一步治疗 SIL(7.5% vs. 4.8%,p<0.001),与阴性边缘相比。
大多数(85%)边缘阳性的女性没有残留/复发 HSIL,其中细胞学密切监测是合理的选择。对于边缘阳性、宫颈内腺上皮受累以及年龄较大或无法进行随访的女性,可以考虑重复切除。